988 - A Mental Health Lifeline
988 is a mental health crisis line. A shortened version of the 1-800-273-TALK (8255), this line is specifically used for any mental health related emergency.
SAINT Protocol Now Cleared by the FDA
The Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT) Neuromodulation System to treat major depressive disorder (MDD) in adults who have failed to achieve adequate improvements with antidepressant medications. The treatment consists of 10 daily sessions over the course of 5 days (50 treatments total). The location of the stimulation is based on individualized fMRI with neuronavigational targeting equipment. Even though this protocol has FDA clearance, most insurances do not yet offer coverage for this type of treatment. If you are interested with the treatment or would like to speak to a mental health professional please give us a call or send us an email.
Read about the FDA approval and protocol here.
You Might Also Enjoy...
TMS and Its Wide Application
FDA's approval of TMS for Major Depressive Disorder (MDD) in 2008 has sparked researchers to take a dive and explore further implications of TMS for other drug-resistant psychiatric disorders.
Study Supports the Use of Repetitive TMS for Treatment Resistant Depression
A study in France has found that 1 in 4 individuals may achieve remission for treatment resistant depression with repetitive TMS.
List of TMS Devices that Have Been Cleared by the FDA to Treat Major Depression
Here is a list of TMS devices currently cleared by the FDA to treat major depression.
TMS for Parkinson's Disease
Read about how transcranial magnetic stimulation (TMS) can be used to help target the motor symptoms of Parkinson's disease.
Preliminary Data Shows How TMS May Treat Depressive Symptoms in Patients with Multiple Sclerosis
Read about how Transcranial Magnetic Stimulation (TMS) may help with the depressive symptoms that patients with multiple sclerosis experience.